Regarding : healthunlocked.com/thyroidu...
I’ve today received an email letter from Sarah Wollaston, MP and Chair of Health Committee. Seems like she is taking some action.
Thank you for your email of 5 June concerning Liothyronine (T3) and the investigation in the Times newspaper reporting extortionate costs of generic drugs to the NHS.
I was deeply concerned by the issues raised in the Times and wrote to the Secretary of State to seek assurance that such allegations are appropriately investigated as a matter of urgency and to identify and investigate other pricing irregularities if they exist. The Secretary of State’s reply to my letter was published on our website earlier this week
The Health Committee awaits with interest the decision or action taken by the Department as a result of the Competition and Markets Authority’s investigation and the Department’s own consultation on the pricing of branded health service medicines.
Thank you for writing to me.
Dr Sarah Wollaston MP
Chair of the Committee